Most Patients Taking Opioids Open to Receiving Naloxone Rx

This article originally appeared here.
Share this content:
Most Patients Taking Opioids Open to Receiving Naloxone Rx
Most Patients Taking Opioids Open to Receiving Naloxone Rx

TUESDAY, Sept. 13, 2016 (HealthDay News) -- A new, small survey of patients taking opioids found that most were willing to also fill prescriptions for naloxone. The report was published in the September/October issue of the Annals of Family Medicine.

Phillip Coffin, M.D., of the San Francisco Department of Public Health's Center for Public Health Research, and colleagues surveyed 60 adults who received opioid prescriptions from 2013 to 2015. Ninety percent had never been prescribed naloxone before; 82 percent had filled new prescriptions for the medication.

The researchers found that only 13 were concerned about being offered naloxone, with some saying they felt judged or offended. Almost all of the patients (97 percent) said they thought that everyone who gets a prescription for an opioid should also be prescribed naloxone. More than one-third of the patients (37 percent) reported beneficial behavior changes. Of those, eight specifically pointed to improvements like handling dosing and the timing of doses in a safer manner. Three patients said they were actually administered naloxone for an overdose over a period of about six months.

"Physicians should absolutely consider prescribing naloxone with opioids," Coffin told HealthDay. "Some providers have voiced concern that prescribing naloxone to patients could result in negative patient reactions. We found that this was rare. Even among the few with a negative initial reaction, all but one patient still wanted naloxone again in the future."

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

USPSTF Urges Abuse Screening for Reproductive-Aged Women

USPSTF Urges Abuse Screening for Reproductive-Aged Women

Evidence lacking for assessing balance of benefits, harms of screening for abuse of seniors, vulnerable

Five-Day Nitrofurantoin Beats Single-Dose Fosfomycin for UTI

Five-Day Nitrofurantoin Beats Single-Dose Fosfomycin for UTI

Increased likelihood of clinical and microbiological resolution for uncomplicated UTI in women

Exercise Intervention Doesn't Improve Walking Ability in PAD

Exercise Intervention Doesn't Improve Walking Ability in PAD

Smaller mean change from baseline to follow-up in 6-minute walking distance with exercise intervention

is free, fast, and customized just for you!

Already a member?

Sign In Now »